Do you offer maintenance niraparib for a stage IIB endometrioid wtBRCA HRD unknown ovarian carcinoma patient after completing front line platinum therapy, or do you reserve it for advanced stages only (III-IV)?
PRIMA included Stage III-IV patients however NCCN guidelines include Stage II-IV patients.